Originally published on Technavio:Stem Cell Manufacturing Market Analysis Across North America, Europe, Asia, and ROW - Covering the US, Germany, UK, China, Japan - Size and Forecast for 2022-2026

The expected increase in the market share of stem cell manufacturing is USD 6.77 billion, with a Compound Annual Growth Rate (CAGR) of 9.69% from 2021 to 2026. Market growth is contingent on various factors, such as the escalating prevalence of chronic disorders and the burgeoning demand for personalized medicines. Lifestyle changes have led to an upswing in disease rates across all socioeconomic classes, driving the need for stem cells and contributing to market expansion. This market analysis and report provide detailed insights into key market

Market Dynamics
The notable driver for market growth is the increasing prevalence of several chronic disorders, although factors like a shortage of trained professionals may impede it. A comprehensive analysis of these drivers aids in determining end goals and refining marketing strategies for a competitive edge.

Primary Driver
A key factor fueling global market growth is the rising prevalence of chronic disorders. Four major chronic diseases - cardiovascular disease (CVD), cancer, chronic obstructive pulmonary disease, and type 2 diabetes - are attributable to high blood pressure, high blood cholesterol, overweight, physical inactivity, unhealthy diet, and tobacco use.

Key Trend
The key factor driving market growth is the increasing demand for personalized medicines. Personalized treatments, based on patient characteristics, needs, and preferences, are gaining traction. Research organizations explore the development of personalized treatments using mesenchymal cells, known for their benefits such as a low risk of immune rejection, limited need for anti-rejection drugs, and reduced chances of graft-versus-host disease (GvHD). Mesenchymal stem cells (MSCs) in the vascular region of the bone marrow, serving as the cellular support of the HSC niche, have improved engraftment rates and reduced GvHD during HSCT. These factors are expected to support market growth and trends during the forecast period.

Key Challenge
A key challenge to market growth is the scarcity of trained professionals for successful procedures. Multiple studies in the US indicate a dire shortage of professionals, with less than 5,000 genetic counselors currently available. Due to the lack of specific training programs for physicians, the shortage of genetic experts is predicted to persist until 2024
Stem Cell Manufacturing Market Segmentation by Region

For deeper insights into the market share across various regions, request a FREE sample now!

North America is expected to contribute 42% to the market's growth during the forecast period, with the US being a key market. Market growth in North America is anticipated to outpace that in Europe and ROW due to a well-developed healthcare system facilitating the establishment of biotechnology solutions in the market and high disposable income allowing for the adoption of expensive therapies. This market growth and forecasting report provides detailed information on competitive intelligence, marketing gaps, and regional opportunities, assisting companies in creating efficient business plans.

Market Segmentation

To Learn deeper into this report , View Sample PDF
The market witnesses substantial revenue driven by intensive research studies and industry trend analysis. Pricing and patent analyses, coupled with conference materials, inform buying behavior among key stakeholders. Growth factors include increased awareness of products, technical advancements, and regulatory policies. Stem cell banking, along with advanced laboratory equipment and facilities ensuring sterility, requires skilled personnel, including scientists, technicians, and quality assurance experts.

For more information please contact.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/